Honig Peter 4
4 · Karyopharm Therapeutics Inc. · Filed May 20, 2022
Insider Transaction Report
Form 4
Honig Peter
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2022-05-19+10,995→ 10,995 totalExercise: $5.65Exp: 2032-05-18→ Common Stock (10,995 underlying)
Footnotes (1)
- [F1]This option vests as to 100% of the underlying shares on the earlier of May 19, 2023 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc.